Marketwatch Tatva Chintan Pharma Receives Sebi Nod For Rs 450 crore IPO Admin July 12, 2021 Tatva Chintan Pharma IPO: The IPO will consist of fresh issuance of shares worth Rs 225 crore and an offer of sale worth Rs 225 crore by existing promoters and shareholders NDTV Profit – Latest Share on Facebook Tweet it Pin it Share it Email